For the quarter ending 2025-09-30, MBRX has $20,353K in assets. $47,273K in debts. $6,703K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 6,703 | 7,557 | ||
| Prepaid expenses and other current assets | 1,182 | 1,519 | ||
| Total current assets | 7,885 | 9,076 | ||
| Intangible assets | 11,148 | 11,148 | ||
| Other non-current assets | 900 | 900 | ||
| Operating lease right-of-use asset | 343 | 370 | ||
| Furniture and equipment, net | 77 | 99 | ||
| Total assets | 20,353 | 21,593 | ||
| Accounts payable | 2,116 | 3,721 | ||
| Accrued expenses and other current liabilities | 3,566 | 4,192 | ||
| Total current liabilities | 5,682 | 7,913 | ||
| Operating lease liability - long-term, net of current portion | 258 | 292 | ||
| Warrant liability | 41,333 | 20,553 | ||
| Total liabilities | 47,273 | 28,758 | ||
| Common stock, 0.001 par value 500,000,000 shares authorized 49,498,576 and 3,378,895 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 49 | 30 | ||
| Additional paid-in capital | 194,631 | 160,286 | ||
| Accumulated other comprehensive loss | -44 | -38 | ||
| Accumulated deficit | -221,556 | -167,443 | ||
| Total stockholders equity (deficit) | -26,920 | -7,165 | ||
| Total liabilities and stockholders equity | 20,353 | 21,593 | ||
Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech, Inc. (MBRX)